Kemal Malik
CIK 1797921 · last filed 2026-01-06
Kemal Malik is a corporate insider who has filed 7 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for RNAC, was dated Jan 6, 2026. Current disclosed insider exposure totals $105.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$105.9K
2
7
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RNAC | Director | 11,133 | $9.51 | $105.9K | $0 | 3 | 2026-01-06 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 0 | $178.75 | $0 | $0 | 4 | 2021-11-22 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | RNAC | Grant (A) | +2,600 | $0 | EDGAR |
| 2025-01-06 | RNAC | Grant (A) | +2,600 | $0 | EDGAR |
| 2024-07-03 | RNAC | Grant (A) | +5,933 | $0 | EDGAR |
| 2021-11-22 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | −1,622 | $0 | EDGAR |
| 2021-02-02 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | +1,622 | $0 | EDGAR |
| 2020-02-10 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | ACCELERON PHARMA INC (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |